We curated our favorite podcasts, articles and videos so you could learn about the global health threat of antimicrobial resistance, unique challenges facing product developers, and how CARB-X is helping to accelerate new products to help save patients’ lives and slow the spread of resistance.
02.14.2023 | Podcast | One World, One Health
Treating antibiotics as infrastructure
Host Maggie Fox speaks with Kevin Outterson about how antibiotics should be treated as infrastructure, and why companies making new drugs that address antibiotic resistance should be paid upfront for their work.
01.19.2023 | Podcast | Antibiotic Resistance Awareness Podcast
Interview with Su Chiang from CARB-X, a global antibiotic innovation accelerator
Host Ethan Rhee speaks with Su Chiang about the challenges facing antibiotic companies and how CARB-X supports the development of new products that address antimicrobial resistance.
12.19.2022 | Podcast | Superbugs Unplugged
The Roller Coaster of Antibiotic Development
Hosts Lance Price and Matthew Wellington discuss with Erin Duffy the global health threat of antimicrobial resistance and how CARB-X is investing in diverse products to help overcome common challenges faced in low- and middle-income countries.
11.10.2022 | Podcast | Let's Talk Cancer
Antimicrobial Resistance: The Silent Pandemic
Host Cary Adams talks to Kevin Outterson about the increasing threat of drug resistance, in particular for cancer patients, and what’s being done to address it.
09.09.2022 | Podcast | Infectious Conversations
CARB-X & Sepsis Awareness Month
Host Candace DeMatteis speaks with Erin Duffy during Sepsis Awareness Month about the problems with the current pipeline for antimicrobial medications and how CARB-X supports companies that are working to bring the latest innovations to patients.
07.28.2022 | Podcast | MTPConnect
CARB-X: Accelerating Global Antibacterial Innovation to Combat Resistance
Hosts Caroline Duell and Andrew Bowskill speak with Richard Alm about the threat of antimicrobial resistance, the need to take a ‘village approach’ to develop new life-saving antimicrobial treatments, and why it’s time for an AMR accelerator in Australia.
06.06.2022 | Video | CARB-X
How CARB-X is Addressing AMR
Drug-resistant bacteria kill >1M people per year. This is the story about how CARB-X is helping to address the global health threat of AMR.
05.19.2022 | Article | The Brink
Can We Prevent Antibiotic Resistance?
The Brink examines the progress CARB-X has made over six years as it aims to strengthen the pipeline of new products that address the antibiotic resistance crisis.
12.21.2021 | Podcast | Phage Therapy Today
Investment Strategies in Phage Therapy
Host Steven Yang speaks with Richard Alm about how CARB-X is investing in phage therapy.
10.13.2021 | Podcast | The State of Health
Antibiotic Resistance: How CARB-X helps companies get a running start
Host Gunnar Esiason speaks with Kevin Outterson about unique challenges companies face while developing novel antibiotics, how CARB-X supports these product developers, and potential policy solutions.
08.09.2020 | Article | Boston Globe
Racing the clock to stop drug-resistant superbugs
The Boston Globe explores the history of CARB-X, and how it is helping to address the global health crisis of antimicrobial resistance.